Ad is loading...
IGAAX
Price
$36.54
Change
-$0.20 (-0.54%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

IGAAX vs VTSNX

Header iconIGAAX vs VTSNX Comparison
Open Charts IGAAX vs VTSNXBanner chart's image
American Funds Intl Gr and Inc A
Price$36.54
Change-$0.20 (-0.54%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
IGAAX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IGAAX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGAAX is a StrongBuy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. IGAAX (14.8B). VTSNX pays higher dividends than IGAAX: VTSNX (3.29) vs IGAAX (2.28). IGAAX was incepted earlier than VTSNX: IGAAX (16 years) vs VTSNX (14 years). IGAAX is a more actively managed with annual turnover of: 31.00 vs. VTSNX (4.00). IGAAX has a lower initial minimum investment than VTSNX: IGAAX (250) vs VTSNX (5000000). VTSNX (10.92) and IGAAX (10.72) have marching annual gain over last year. VTSNX return over 5 years is better than : 15.91 vs. IGAAX (13.26).
IGAAXVTSNXIGAAX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years14 years-
Gain YTD4.0214.53589%
Front LoadN/AN/A-
Min. Initial Investment25050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets14.8B442B3%
Annual Yield % from dividends2.283.2970%
Returns for 1 year10.7210.9298%
Returns for 3 years-7.68-5.86131%
Returns for 5 years13.2615.9183%
Returns for 10 years15.9629.8154%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals